Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Biomedicines|September 27, 2025
Allogeneic NKG2D CAR-T Cell Therapy: A Promising Approach for Treating Solid TumorsSabir A Mukhametshin, Elvina M Gilyazova, Damir R Davletshin, et al.Journal of Experimental & Clinical Cancer Research : CR|February 19, 2025
Highlighting recent achievements to advance more effective cancer immunotherapyBeatrice Belmonte, Sheila Spada, Paola Allavena, et al.Advanced Healthcare Materials|February 12, 2026
Patient-Derived 3D Bioprinted Cardiac Organoid Constructs Reveal Key Pathological Features of Duchenne Muscular DystrophyVittoria Marini, Margalida Campaner Socias, Andreas Dimopoulos, et al.Cancers|March 13, 2024
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in RhabdomyosarcomaSilvia Codenotti, Leonardo Sandrini, Delia Mandracchia, et al.Cell Death & Disease|July 7, 2026
Unraveling the dual roles of MICAL2 in skeletal muscle physiology and fusion negative rhabdomyosarcoma tumor progressionAshley Wang, Nefele Giarratana, Simen Cassiman, et al.EMBO Reports|September 10, 2020
The actin modulator hMENA regulates GAS6-AXL axis and pro-tumor cancer/stromal cell cooperationRoberta Melchionna, Sheila Spada, Francesca Di Modugno, et al.Oncogene|June 17, 2018
hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axisFrancesca Di Modugno, Sheila Spada, Belinda Palermo, et al.Cell Reports|January 12, 2025
miR-449a/miR-340 reprogram cell identity and metabolism in fusion-negative rhabdomyosarcomaEnrico Pozzo, Laura Yedigaryan, Nefele Giarratana, et al.Communications Biology|February 27, 2020
Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigensAlessio Grimaldi, Ilenia Cammarata, Carmela Martire, et al.Ebiomedicine|February 10, 2024
Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancerFrancesca Di Modugno, Anna Di Carlo, Sheila Spada, et al.Pageof 5